IRIS
CHIMENTI, SERGIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 44.031
EU - Europa 4.163
AS - Asia 1.534
AF - Africa 63
SA - Sud America 45
OC - Oceania 38
Continente sconosciuto - Info sul continente non disponibili 22
Totale 49.896
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 43.959
CN - Cina 915
UA - Ucraina 770
DE - Germania 694
IT - Italia 490
IE - Irlanda 480
SE - Svezia 389
FR - Francia 341
GB - Regno Unito 302
KR - Corea 171
FI - Finlandia 168
PL - Polonia 148
RU - Federazione Russa 91
IN - India 74
CA - Canada 60
NL - Olanda 45
BE - Belgio 44
PK - Pakistan 40
JP - Giappone 37
AU - Australia 34
HK - Hong Kong 34
CH - Svizzera 31
EG - Egitto 31
ES - Italia 31
VN - Vietnam 31
TR - Turchia 29
ID - Indonesia 26
BR - Brasile 25
RO - Romania 25
IR - Iran 23
KG - Kirghizistan 21
EU - Europa 19
UZ - Uzbekistan 19
SG - Singapore 18
TW - Taiwan 18
HU - Ungheria 17
PH - Filippine 15
SK - Slovacchia (Repubblica Slovacca) 15
AE - Emirati Arabi Uniti 14
IL - Israele 14
GR - Grecia 13
EE - Estonia 10
NG - Nigeria 10
PT - Portogallo 10
MX - Messico 9
ZA - Sudafrica 9
CZ - Repubblica Ceca 8
IQ - Iraq 8
AT - Austria 7
MY - Malesia 7
CL - Cile 6
DK - Danimarca 6
HR - Croazia 6
TH - Thailandia 6
NO - Norvegia 5
PE - Perù 5
RS - Serbia 5
AR - Argentina 4
BJ - Benin 4
LT - Lituania 4
LV - Lettonia 4
MA - Marocco 4
NZ - Nuova Zelanda 4
EC - Ecuador 3
KW - Kuwait 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BA - Bosnia-Erzegovina 2
CO - Colombia 2
ET - Etiopia 2
LB - Libano 2
MD - Moldavia 2
SA - Arabia Saudita 2
A1 - Anonimo 1
BH - Bahrain 1
CR - Costa Rica 1
CY - Cipro 1
GP - Guadalupe 1
KH - Cambogia 1
LK - Sri Lanka 1
MG - Madagascar 1
NA - Namibia 1
NP - Nepal 1
OM - Oman 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
UG - Uganda 1
Totale 49.896
Salva come PNG Salva come JPEG
Città #
Woodbridge 13.836
Wilmington 10.937
Houston 9.548
Fairfield 1.612
Ann Arbor 1.279
Chandler 1.067
Ashburn 812
Jacksonville 684
Seattle 673
Cambridge 569
Dublin 477
Medford 387
Dearborn 291
Beijing 288
Zhengzhou 265
New York 206
Lawrence 183
Kraków 137
Rome 118
San Diego 98
Mülheim 87
Menlo Park 86
Shanghai 79
Redwood City 62
Boardman 40
San Mateo 39
Hefei 37
Milan 36
Nanjing 35
London 32
Norwalk 32
Brussels 29
University Park 28
Guangzhou 25
Falls Church 24
Toronto 24
Verona 24
Hangzhou 21
Jönköping 20
Kunming 20
Mountain View 20
Palo Alto 20
Nanchang 19
Dong Ket 18
Auburn Hills 17
Duncan 14
Tokyo 14
Los Angeles 13
Redmond 13
Detroit 12
Dubai 12
Fuzhou 12
Jakarta 12
Helsinki 11
Jinan 11
Phoenix 11
Stockholm 11
Budapest 10
Central 10
Madrid 10
Saint Petersburg 10
Salcedo 10
Cairo 9
Hounslow 9
Lahore 9
Ottawa 9
Pune 9
Bucharest 8
Clearwater 8
Hanoi 8
Lagos 8
Nürnberg 8
Paris 8
Tallinn 8
Wuhan 8
Augusta 7
Melbourne 7
Seoul 7
São Paulo 7
Utrecht 7
Washington 7
Berlin 6
Chengdu 6
Chicago 6
Groningen 6
Indiana 6
Islamabad 6
Leawood 6
Napoli 6
New Delhi 6
Taipei 6
Amsterdam 5
Catania 5
Ferrara 5
Hebei 5
Istanbul 5
Lima 5
Montreal 5
Pisa 5
San Francisco 5
Totale 44.793
Salva come PNG Salva come JPEG
Nome #
European S3-guidelines on the systemic treatment of psoriasis vulgaris 1.341
Long-term use of a new topical formulation containing piroxicam 0.8% and sunscreen: efficacy and tolerability on actinic keratosis. A proof of concept study 1.161
AISI: A New Disease Severity Assessment Tool for Hidradenitis Suppurativa 461
Atopic dermatitis and dental manifestations 459
Adalimumab for the treatment of severe psoriasis and psoriatic arthritis 456
Alopecia areata e trachionichia associato a sindrome da insufficienza endocrina plurighiandolare. 455
Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis 438
-174G/C IL-6 gene promoter polymorphism predicts therapeutic response to TNF-α blockers 429
Effects of TNF-α and IL-1 β on the activation of genes related to inflammatory, immune responses and cell death in immortalized human HaCat keratinocytes 423
Clinical aspects of the oral cavity in patients with psoriasis: an initial study and a proposal of a new evaluation method 423
Superficial and nodular basal cell carcinomas treated with an immune response modifier: a report of seven patients 422
Treatment of trachyonychia with tazarotene 421
Psoriasis Phenotype in Inflammatory Bowel Disease: A Case-Control Prospective Study 419
Successful treatment of multiple filiform facial warts with imiquimod 5% cream in a patient infected by human immunodeficiency virus 417
Psoriasis, kaposi's sarcoma and hodgkin's disease in a patient with down's syndrome [2] 417
Tazarotene 0-1% gel for psoriasis of the fingernails and toenails: an open, prospective study [9] 411
Combination of low-dosage cyclosporine and topical pimecrolimus in severe atopic dermatitis with chronic hepatitis B [10] 408
Apremilast for the treatment of psoriasis. 405
Exclusion of CARD15/NOD2 as a candidate susceptibility gene to psoriasis in the Italian population 404
Increased levels of IL-17 in tear fluid of moderate-to-severe psoriatic patients is reduced by adalimumab therapy 404
Trimethoprim-sulfamethoxazole induced erythrodermic psoriasis 403
Actinic keratosis treated with an immune response modifier: a case report of six patients 402
IL-21 Promotes Skin Recruitment of CD4+ Cells and Drives IFN- -Dependent Epidermal Hyperplasia 402
Experimental T cells immunotherapy by tumor-loaded ECP-generated dendritic antigen presenting cells 402
Tazarotene as alternative topical treatment for onychomycosis 401
Lung nodule and facial erythematous plaques: a quiz 397
New topical treatments for psoriasis 397
Reply to Scalone and Cortesi: ‘‘Cost-Utility Analysis of Biologic Therapies to Treat Chronic Plaque Psoriasis in Italy: The Importance of Using Updated and Adequate Social Tariffs to Calculate QALYs’’ 395
Alopecia areata e trachionichia associato a sindrome da insufficienza indocrina plurighiandolare 393
Golimumab in Patients Affected by Moderate to Severe Psoriatic Arthritis: An Open-Label Study in Thirty-Two Patients Previously Treated with Other Biologics 391
Lack of efficacy of imiquimod in patients with basal cell carcinoma previously treated with rituximab for B cell lymphoma: two case reports 391
Psoriasis, from pathogenesis to therapeutic strategies: IL-21 as a novel potential therapeutic target 390
Evaluation of clinical and ultrasonographic parameters in psoriatic arthritis patients treated with adalimumab: a retrospective study 388
Real-life 9-year experience with adalimumab in psoriasis and psoriatic arthritis: results of a single-centre, retrospective study. 388
Psoriatic arthritis and CARD15 gene polymorphisms: no evidence for association in the Italian population 387
The significance of the development of antinuclear antibodies during infliximab treatment 386
Efficacy of short-term cyclosporine treatment to control psoriasis-related events during efalizumab therapy 382
Remission and time of resolution of nail psoriasis during infliximab therapy [27] 381
Chronic mucocutaneous candidiasis and alopecia areata as cutaneous expressions of autoimmune polyglandular syndrome type I 381
Severe acne successfully treated with etanercept 378
Topical lactoferrin can improve stable psoriatic plaque 378
PSORS2 markers are not associated with psoriatic arthritis in the Italian population 377
Bullous dermatomyositis: A marker of poor prognosis and aggressive internal malignancy? 376
Continuous treatment of plaque-type psoriasis with etanercept: An observational long-term experience 375
Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics 374
Effect of anti-tumor necrosis factor-alpha therapies on body mass index in patients with psoriasis 374
Adalimumab in the treatment of plaque-type psoriasis and psoriatic arthritis 374
Oral lichen planus: Novel acquisitions in the pathogenesis and treatment 373
Local treatment of chronic cutaneous leg ulcers with recombinant human granulocyte-macrophage colony-stimulating factor. 371
Stress reactivity in psoriatic patients 369
The impact of biologic therapy in chronic plaque psoriasis from a societal perspective: an analysis based on Italian actual clinical practice 369
Treatment of lentigo maligna with tazarotene 0.1% gel 367
Phrynoderma: a cutaneous sign of an inadequate diet 365
Topical use of calcitriol 3 microg/g ointment in the treatment of mild-to-moderate psoriasis: results from an open-label study 364
Characterization of the loricrin (LOR) gene as a positional candidate for the PSORS4 psoriasis susceptibility locus 363
Infliximab therapy induces increased polyclonality of CD4+CD25+ regulatory T cells in psoriasis. 362
Bowenoid papulosis and invasive Bowen's disease: a multidisciplinary approach 362
Usefulness of QuantiFERON®-TB Gold test in psoriatic patients under treatment with tumour necrosis factor blockers 361
Topical treatment of basal cell carcinoma with tazarotene: a clinicopathological study on a large series of cases 360
Co-localization of susceptibility loci for psoriasis (PSORS4) and atopic dermatitis (ATOD2) on human chromosome 1q21 358
Peculiar clinical and dermoscopic remission pattern following imiquimod therapy of basal cell carcinoma in seborrhoeic areas of the face 356
Diagnosis of pigmented skin lesions by dermoscopy: web-based training improves diagnostic performance of non-experts 354
Systemic therapy of primary cutaneous B-cell lymphoma, marginal zone type, with rituximab, a chimeric anti-CD20 monoclonal antibody 353
The tumor suppressor activity of IKK alpha in stratified epithelia is exerted in part via the TGF-beta anti proliferative pathway 353
What happened after the clinical trials: Long-term safety and efficacy of ustekinumab in daily clinical practice 353
Quality of life of psoriatic patients evaluated by a new psychometric assessment tool: PsoDisk 351
Localized morphea treated with imiquimod 5% and dermoscopic assessment of effectiveness 350
High-dose initiation of etanercept in psoriatic arthritis and plaque psoriasis: Efficacy, safety and impact on patients' quality of life 350
Melanoma-associated markers expression in blood: MUC-18 is associated with advanced stages in melanoma patients 346
Cerebriform plantar hyperplasia: the clinico-pathological hallmark of Proteus syndrome 346
Zosteriform metastasis of occult bronchogenic carcinoma 346
The first skin cancer screening day at the Italian parliament: A Euromelanoma initiative 346
Use of biological drugs in patients with psoriasis and psoriatic arthritis in Italy: Results from the PSONG survey 346
Prevention of Dermatologic Side Effects of Bimatoprost 0.03% Topical Therapy 345
Prospective assessment of body weight and body composition changes in patients with psoriasis receiving anti-TNF-α treatment 345
Pharmacodynamic assessment of apremilast for the treatment of moderate-to-severe plaque psoriasis 344
Tofacitinib for the treatment of psoriasis 343
Dose adjustment of biologic therapies for psoriasis in dermatological practice: a retrospective study 343
A 2-year history of an asymptomatic scalp nodule - Cutaneous metastasis from renal cell carcinoma. 340
TNF-α antagonists and nail psoriasis: An open, 24-week, prospective cohort study in adult patients with psoriasis 340
Disseminated pagetoid reticulosis presenting as cytotoxic CD4/CD8 double negative cutaneous T-cell lymphoma 334
Influence and variation of the body mass index in patients treated with etancercept for psoriasis 334
Erysipeloid cutaneous metastasis from bladder carcinoma 333
Metastatic Crohn's disease of the forehead 333
Dermatitis artefacta in sporadic sclerodermoid hepatitis C virus-associated porphyria cutanea tarda 331
Pyoderma vegetans and ulcerative colitis 330
Cyclosporine: a novel therapeutic approach for Burning Mouth Syndrome 329
HIV-associated primary cutaneous anaplastic large cell lymphoma: A clinicopathological subset with more aggressive behavior? Case report and review of the literature 328
Green sweating spots on hands and feet: unusual expression of hyperbilirubinemia 327
Chronically Sun-damaged Melanomas Express Low Levels of Nuclear Glutathione-S-transferase-π: An Epidemiological and Clinicopathological Study in Italy 327
Evidence of increased apoptosis and reduced proliferation in basal cell carcinomas treated with tazarotene 325
Zosteriform metastasis of occult bronchogenic carcinoma 324
Small molecules and antibodies for the treatment of psoriasis: A patent review (2010–2015) 322
Ichthyosiform mycosis fungoides: A neoplastic acquired ichthyosis [5] 321
Dermatomyositis associated with ovarian transitional cell carcinoma 321
Does metabolic syndrome influence psoriasis? 321
Kaposi's sarcoma in a patient treated with imatinib mesylate for chronic myeloid leukemia 321
Insight into genetics of atopic dermatitis: future approaches and directions 319
Efficacy and safety of long-term infliximab therapy in moderate to severe psoriasis and psoriatic arthritis 317
Severe erytrodermic psoriasis in child twins: From clinical-pathological diagnosis to treatment of choice through genetic analyses: Two case reports 317
Totale 38.845
Salva come PNG Salva come JPEG
Categoria #
all - tutte 94.371
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 94.371
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192.653 0 0 0 0 0 0 0 0 0 0 1.329 1.324
2019/202012.667 1.119 1.010 876 1.213 1.010 1.364 1.157 1.198 1.073 1.105 674 868
2020/20217.104 777 802 745 867 634 674 794 695 313 240 409 154
2021/20222.158 88 275 151 139 59 177 104 115 146 186 142 576
2022/20232.793 260 230 142 409 236 586 183 156 290 27 172 102
2023/2024956 120 52 81 50 105 290 81 106 23 38 10 0
Totale 50.691